We are happy to announce that the Innovation Fund Denmark has approved that their generous grant (15.6 mio DKK) to the establishment of the NeuroPharm center can be spend over a two year longer period, i.e. until the end of 2022.

With this extended time frame and thanks to a substantial amount of additional funding that we have successfully managed to acquire since the center was launched in the beginning of 2015, we are now in an optimal position to conduct the full NeuroPharm research program. We look forward to many interesting results.